Tru-Cut Biopsy (Core Needle Biopsy): Introduction, Procedure, Application, and Keynotes

Introduction

A Tru-cut biopsy, also known as a core needle biopsy (CNB), is a minimally invasive diagnostic procedure used to extract a small, solid cylinder (core) of tissue from a suspicious mass. Unlike Fine Needle Aspiration (FNA), which only collects individual cells, a Tru-cut biopsy preserves the tissue architecture, allowing pathologists to perform more detailed histological examinations, including tumor staging and grading.

Procedure Steps

The procedure typically takes 15–30 minutes and is performed in an outpatient setting.

1. Preparation: The patient is positioned on an exam table. The area is cleaned with antiseptic, and a local anesthetic (like lidocaine) is injected to numb the site.
2. Incision: A tiny “nick” or stabbing incision (often using a #11 scalpel blade) is made in the skin to facilitate needle entry.
3. Insertion & Guidance: A hollow needle is inserted and guided to the target mass using imaging such as ultrasound, CT, or mammography to ensure precision.
4. Tissue Capture: The biopsy device is “fired” (often with a loud clicking sound). An inner trocar with a sample notch captures the tissue, and an outer sheath quickly slides over it to cut and trap the core.
5. Extraction: The needle is withdrawn, and the cylindrical sample (typically 1–2 mm thick) is placed in a preservative like formalin for lab analysis.
6. Aftercare: Firm pressure is applied to the site for several minutes to control bleeding, followed by the application of a sterile bandage.

Clinical Applications

Tru-cut biopsies are a “standard of care” for diagnosing various solid tumors:

• Oncology: Used for the diagnosis and staging of cancers in the breast, liver, prostate, and lungs.
• Gastroenterology: Assessment of liver diseases and gastrointestinal lesions.
• Musculoskeletal: Evaluation of bone and soft tissue tumors.
• Other Areas: Increasingly used for maxillofacial pathologies, salivary glands, and lymph nodes.

Keynotes & Advantages

• Accuracy: Boasts a high diagnostic accuracy (often exceeding 90–97%), reducing the need for more invasive surgical biopsies.
• Comprehensive Data: Provides enough tissue for immunohistochemistry (IHC) and genetic testing (e.g., BRCA mutations), which is vital for personalized treatment.
• Minimal Recovery: Patients can usually return to normal activities within 24–48 hours.
• Safety: Complication rates are low (around 1.3%) and typically limited to minor bruising, mild pain, or localized infection.

Further Readings

1. https://my.clevelandclinic.org/health/diagnostics/core-needle-breast-biopsy
2. https://www.orthobullets.com/pathology/8082/biopsy-principles
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC8313593/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10198176/
5. https://www.centermed.com.tr/en/tru-cut-biopsy-a-reliable-method-used-in-breast-biopsy
6. https://akshatdiagnostics.com/blogs/tru-cut-biopsy-a-precise-diagnostic-procedure-for-tissue-analysis/
7. https://www.interventionaloncology.center/breast-biopsy
8. https://www.komen.org/breast-cancer/diagnosis/biopsies/core-needle/
9. https://cancer.ca/en/treatments/tests-and-procedures/core-biopsy